Skip to content
The U.S. Department of Agriculture (USDA) on Nov. 12 announced that biotech plants made through modifications that could have been achieved by conventional breeding can be […]
APHIS exempts more types of biotech plants from regulation Read More »
“We are seeing an ongoing lack of participation by diverse groups in trials,” said Wayne Frederick, M.D., MBA, President Emeritus of Howard University and
How clinical trial diversity is the path to health equity Read More »
On November 19, the Biotechnology Innovation Organization (BIO) Clinical Trial Diversity Summit brought together a dynamic mix of researchers, industry leaders, policymakers, and community
BIO Clinical Trial Diversity Summit explores advancing equity in clinical research Read More »
Insurers and pharmacy benefit managers (PBMs) in search of profits are preventing patients from getting the drugs they need, according to the latest episode
How utilization management blocks patient access Read More »
When Peggy Lillis was put on an antibiotic to treat an abscess after a root canal, her family had no idea of what was
4 things to know during C. diff Awareness Month Read More »
As biotech breakthroughs enable remarkable advances in treatment and prevention of disease, we need similar levels of innovation in access, so patients benefit from
BIO CEO John F. Crowley calls for innovation in access at Milken Health Summit Read More »
As the world gathers in Baku, Azerbaijan, for the COP29 United Nations Climate Summit, the Biotechnology Innovation Organization (BIO) is ensuring biotech’s role in
BIO to present biotech’s benefits for climate and food at COP29 Read More »
Biotech apples designed to last longer, taste great, and make superior cider were the stars when Rep. Dan Newhouse (R-WA) toured Okanagan Specialty Fruits’
Rep. Newhouse: ‘Tremendous potential’ for biotech apples in U.S. food supply Read More »
It is open enrollment season for Medicare Part D, and the patient-led advocacy coalition MAPRx is helping patients get the coverage they need. Open
MAPRx is helping patients navigate open enrollment Read More »
Drugmakers dealing with the complex process of developing medicines must be allowed to decide against trying to bring a drug to market, the Biotechnology
